Year end report 2013-01-01 to 2013-12-31

Research results reinforce our work in the development and commercialization of the diagnosis and treatment of pre-eclampsia.

A1M Pharma Year-end Report 2013

For further information please contact:
Tomas Eriksson, CEO of A1M Pharma AB
Email: te@a1m.se
Phone: 046-286 50 30